The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Cell. Infect. Microbiol.
Sec. Clinical Microbiology
Volume 14 - 2024 |
doi: 10.3389/fcimb.2024.1484448
This article is part of the Research Topic Antiviral Monoclonal Antibody Therapies View all 6 articles
Editorial: Antiviral Monoclonal Antibody Therapies
Provisionally accepted- 1 United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, United States
- 2 Henry M Jackson Foundation for the Advancement of Military Medicine (HJF), Bethesda, Maryland, United States
- 3 Louisiana State University Health Shreveport, Shreveport, Louisiana, United States
- 4 Albert Einstein College of Medicine, New York City, New York, United States
Keywords: Monoclonal Abs, antiviral, SARS-CoV-2, COVID, bispecific Ab
Received: 21 Aug 2024; Accepted: 16 Sep 2024.
Copyright: © 2024 Florez, Jangra and Haslwanter. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Catalina Florez, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, United States
Rohit K. Jangra, Louisiana State University Health Shreveport, Shreveport, 71103, Louisiana, United States
Denise Haslwanter, Albert Einstein College of Medicine, New York City, 10461, New York, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.